Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Research programme: biodefence vaccines - Crucell/Naval Medical Research Center

Drug Profile

Research programme: biodefence vaccines - Crucell/Naval Medical Research Center

Alternative Names: Biodefense vaccines - Crucell/Naval Medical Research Center

Latest Information Update: 16 Jun 2011

Price :
$50 *
Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Crucell; Naval Medical Research Center
  • Developer Naval Medical Research Center
  • Class Anthrax vaccines; Plague vaccines
  • Mechanism of Action Immunostimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No

Highest Development Phases

  • No development reported Anthrax; Yersinia infections

Most Recent Events

  • 06 Mar 2008 Preclinical development is ongoing
  • 07 Aug 2007 Ichor Medical Systems partners with the Naval Medical Research Center to assess Ichor's TriGrid™ Delivery System in the development of a DNA vaccine for anthrax and plague
  • 01 Sep 2005 Preclinical trials in Anthrax in Netherlands (unspecified route)

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top